top of page
Recent News
Nanomerics Continues Support for RSC Broadening Horizons Programme for Fourth Consecutive Year
London, UK – September 2025 Nanomerics Ltd. is proud to reaffirm its commitment to diversity and inclusion in the chemical sciences by...
Sep 9
Investiture of CSO IF Uchegbu DBE
Buckingham Palace London, Thursday 26th June 2025. Nanomerics’ Chief Scientific Officer’s investiture was held at Buckingham Palace on...
Jun 27
Nanomerics Reports Last Volunteer Visit in the OC134 Sunlight Trial; The Sunlight Trial Met Its Primary Endpoints
LONDON, UK / ACCESS Newswire / March 10, 2025 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that it had...
Mar 10
Nanomerics reports complete dosing of the last volunteer in the OC134 SUNLIGHT trial
Nanomerics today announced end of dosing with all volunteers completing the full schedule and without moderate or severe adverse events...
Jan 9
bottom of page